Early Detection: Catching Cancer When It's Curable

(Paperback)

Publishing Details

Classifications

Physical Properties

Description

The Second-Leading Killer in the USA Shouldn't Be This Deadly

Written by Bruce Ratner and Adam Bonislawski, ....

Catching cancer early remains the single best way to combat a disease that is the second-leading killer in both the US and worldwide. But the vast majority of resources in the fight against cancer are devoted to relatively ineffective late stage treatments. 'Early Detection' examines this important anomaly in an accessible and expertly researched survey.

In a co-authorship that brings together the passion and urgency of someone touched deeply by the experience of cancer with the knowledge of a skilled science writer, Ratner and Bonislawski narrate compelling case studies across a range of screening programs and different forms of cancer.

In this book, you'll discover:

• Importance of Early Detection: Understand the critical role early detection plays in combating cancer and why it's more effective than late-stage treatments.
• Expert Insights and Research: Gain knowledge from expertly researched information on various screening programs and the scientific principles behind them.
• Compelling Case Studies: See the personal and emotional side of cancer through stories that bring urgency and passion to the importance of early detection.
• Necessary Social Change: Understand the need for government and medical establishment support in expanding screening resources, particularly to economically disadvantaged and traditionally underserved communities.

Early detection remains our most powerful tool in the fight against cancer, offering hope and better futures for countless individuals.

Pick Up Your Own Copy to Learn How Together, We Can Save Lives with Early Cancer Detection!

Reviews

Praise for the hardback edition:

"A lucid, persuasive case for overhauling diagnosis regimes to catch cancer early rather than late."
Kirkus Reviews

This powerful book makes a decisive argument that our current strategy against cancer would be vastly enhanced if tumors were detected at earlier stages. I wish that every patient, and policy maker, would read and understand the broad implications of this invaluable, highly readable book.
Siddhartha Mukherjee, MD, Cancer Researcher and Pulitzer Prize-Winning Author of The Emperor of All Maladies: A Biography of Cancer

Ive spent the last twenty-five years trying to convey exactly what this deeply personal, insightful and well reported book shouts, that detecting cancers early, when they are the most treatable, is the key to saving countless lives. It is what policymakers need to hear.
Katie Couric, Award-Winning Journalist, New York Times Best-Selling Author of Going There and Co-Founder of Stand Up To Cancer

An engaging, informative and hugely important work that will save lives.
Ken Burns, Grammy and Emmy Award-Winning Filmmaker

Early Detection provides an important look into testing and treatment disparities that exist in cancer care, and thoughtful guidance about how to mitigate these inequities. Expanding access is in everyones best interest as it has the potential to increase the chance of survival while lowering the cost of care.
Selwyn M. Vickers, MD, President and CEO, Memorial Sloan-Kettering Cancer Center

This clear and thoughtful book is a critical step in the fight against cancer. The authors understand our medical system and have proposed comprehensive policies that will save thousands of lives and help eliminate the detection and treatment disparities that we need to end.
Richard I. Beattie, Esq Former Chairman of the Board, Memorial Sloan-Kettering Cancer Center

Bruce Ratner and Adam Bonislawski identify early diagnosis as a critical requirement for better cancer control and their book elegantly explains the need for both existing and new early detection technologies to make it affordable for all. The personal stories in the book that the authors bravely recount make this mission all the more poignant and urgent.
William A. Haseltine, PhD, Chair, Access Health International, Professor, The Feinstein Institute Of Medical Research

Author Bio

In his long career, Bruce Ratner served as New York City's Commissioner of Consumer Affairs, an NYU law professor and the founder, chairman, and CEO of Forest City Ratner Companies, a major property developer. He led the economic revival of Downtown Brooklyn, built the Barclays Center arena, brought the Nets NBA basketball franchise to Brooklyn, and helped restore Times Square, including building The New York Times headquarters. For more than two decades, Mr. Ratner has applied his deep interest and background in the sciences by serving on the boards of Weill Cornell Medicine, the Memorial Sloan-Kettering Cancer Center and the Cold Spring Harbor Laboratory. He also founded the Michael D. Ratner Center for Early Detection of Cancer, in memory of his brother, to advance the cause of expanding the adoption of life-saving cancer screening and research into new diagnostic tests. Through the center, Mr. Ratner has promoted early detection testing for lung cancer, particularly in low income and underserved populations. Mr. Ratner is also Chairman of the Museum of Jewish Heritage A Living Memorial to the Holocaust. He was founding chairman of the New York City Parks Foundation and, for a decade, served as chairman of the board at the Brooklyn Academy of Music.

Adam Bonislawskiis a science writer with more than 10 years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer and early detection. His writing ranges widely over academic research, companies and technologies. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors, and he has scientific and media contacts at many of the major cancer and academic research centers in the United States and Europe. In addition to his work as a science writer, Adam writes about business and real estate for the Wall Street Journal, New York Post, and Commercial Observer.